-+ 0.00%
-+ 0.00%
-+ 0.00%

CYTOKINETICS, INCORPORATED - FDA APPROVES SNDA UPDATING MYQORZO LABEL WITH PHASE 3 MAPLE-HCM DATA

Reuters·11/16/2026 09:00:00

Please log in to view news